d'Amore, F., Gaulard, P., Trümper, L., Corradini, P.
, Kim, W.-S., Specht, L., Bjerregaard Pedersen, M., Ladetto, M. & ESMO Guidelines Committee (2015).
Peripheral T-cell Lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology,
26 Suppl 5, v108-15.
https://doi.org/10.1093/annonc/mdv201
d'Amore, F., Federico, M., de Leval, L., Ellin, F., Hermine, O., Kim, W. S., Lemonnier, F., Vermaat, J. S. P., Wulf, G., Buske, C., Dreyling, M., Jerkeman, M., ESMO Guidelines Committees & EHA Guidelines Committees (2025).
Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆.
Annals of Oncology,
36(6), 626-644.
https://doi.org/10.1016/j.annonc.2025.01.023
d'Amore, F., Federico, M., de Leval, L., Ellin, F., Hermine, O., Kim, W. S., Lemonnier, F., Vermaat, J. S. P., Wulf, G., Buske, C., Dreyling, M., Jerkeman, M. & the ESMO and EHA Guidelines Committees (2025).
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up.
HemaSphere,
9(5), Article e70128.
https://doi.org/10.1002/hem3.70128
Beck Enemark, M., Monrad, I., Madsen, C., Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
Bencardino, M.
, D'Amore, F., Angot, H., Angiuli, L., Bertrand, Y., Cairns, W., Diéguez, M. C., Dommergue, A., Ebinghaus, R., Esposito, G., Komínková, K., Labuschagne, C., Mannarino, V., Martin, L., Martino, M., Neves, L. M., Mashyanov, N., Magand, O., Nelson, P. ... Pirrone, N. (2024).
Patterns and trends of atmospheric mercury in the GMOS network: Insights based on a decade of measurements.
Environmental Pollution,
363(Pt 2), Article 125104.
https://doi.org/10.1016/j.envpol.2024.125104El-Galaly, T. C., Mylam, K., Brown, P., Rossing, M., Gang, A., Haglund, A., Arboe, B., Clausen, M., Jensen, P., Pedersen, M.
, Bukh, A., Amdi Jensen, B., Poulsen, C.
, D'Amore, F. A. & Hutchings, M. (2013).
Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse.
Hematological Oncology,
31.
Madsen, C., Pedersen, M. B., Vase, M. Ø., Segel, E. K.
, Bendix, K., Jensen, BA., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2015).
outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-399.
Madsen, C., Pedersen, M. B., Vase, M. Ø., Bendix, K., Møller, M. B., Johansen, P., Jensen, BA., Munksgaard, L., Brown, P. D. N., Segel, E.
& D'Amore, F. A. (2015).
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-9.
https://doi.org/10.1093/annonc/mdu537
Dupuis, J., Bachy, E., Morschhauser, F., Cartron, G., Fukuhara, N., Daguindau, N., Casasnovas, R. O., Snauwaert, S., Gressin, R., Fox, C. P.
, d'Amore, F. A., Staber, P. B., Tournilhac, O., Bouabdallah, K., Thieblemont, C., André, M., Rai, S., Ennishi, D., Gkasiamis, A. ... Lemonnier, F. (2024).
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
The Lancet Haematology,
11(6), e406-e414.
https://doi.org/10.1016/S2352-3026(24)00102-9Vase, M. Ø., Maksten, E. F.
, Bendix, K., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, Søndergård, E., Nielsen, P. S. & D'amore, F. (2015).
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.
Leukemia & Lymphoma,
56(6), 1677-85.
https://doi.org/10.3109/10428194.2014.966242
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Frederiksen, H., Møller, M. B.
, Clausen, M. R., Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P.
, Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W.
, Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020).
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica,
105(10), 2432-2439.
https://doi.org/10.3324/haematol.2019.225839
Vase, M. Ø., S, E. F.
, Bendix, K., Jespersen, B., Hamilton-Dutoit, S. J., Schwartz, S., Andersen, C.
& D'Amore, F. A. (2013).
Monomorphic PTLD in a danish cohort: HLA tissue subtype matching correlates with survival.
Hematological Oncology,
31, 216.
Toft-Petersen, M.
, Kamper, P., Albertsen, S., Secher, L., Segel, EK., Clausen, M.
& D'Amore, F. A. (2011).
Monocytosis in the peripheral blood at first relapse/progression predicts poorer overall and progression-free survival after autologous hematopoietic stem cell transplantation in Hodgkin lymphoma. Blood,
118, 1559.
d'Amore, F. A., Stribley, JA., Ohno, T., Wu, G., Wickert, RS., Delabie, J., Hinrichs, SH. & Chan, W. C. (1997).
Molecular studies on single cells harvested by micromanipulation from archival tissue sections previously stained by immunohistochemistry or nonisotopic in situ hybridization.
Laboratory Investigation,
76((2)), 219-24.
Luchtel, R. A., Dasari, S., Oishi, N.
, Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J., Wang, X., Katoh, R., Dogan, A., Kip, N. S., Cunningham, J. M., Sun, Z., Baheti, S., Porcher, J. C., Said, J. W., Jiang, L.
, Hamilton-Dutoit, S. J. ... Feldman, A. L. (2018).
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
Blood,
132(13), 1386-1398.
https://doi.org/10.1182/blood-2018-03-838524Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TG. (1996).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Laboratory Investigation,
75((4)), 575-88.
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TC. (1997).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Laboratory Investigation,
76((3)), 439.
Enemark, M. H., Hemmingsen, J. K., Jensen, M. L., Kridel, R.
& Ludvigsen, M. (2024).
Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review.
International Journal of Molecular Sciences ,
25(20), Article 11179.
https://doi.org/10.3390/ijms252011179
Leivonen, S.-K., Icay, K., Jäntti, K., Siren, I., Liu, C., Alkodsi, A., Cervera, A.
, Ludvigsen, M., Hamilton-Dutoit, S. J., d'Amore, F., Karjalainen-Lindsberg, M.-L., Delabie, J., Holte, H., Lehtonen, R., Hautaniemi, S. & Leppä, S. (2017).
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.
Blood Cancer Journal,
7(12), 654. Article 654.
https://doi.org/10.1038/s41408-017-0033-8Andersen, R. K., Hammer, K., Hager, H., Christensen, J. N., Ludvigsen, M., Honoré, B., Thomsen, M.-B. & Madsen, M. (2015).
Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates. Pigment Cell & Melanoma Research.
https://doi.org/10.1111/pcmr.12352
Eyre, T. A., Cwynarski, K.
, d’Amore, F., de Leval, L., Dreyling, M., Eichenauer, D. A., Ferreri, A. J. M., Giné, E., Kersten, M. J., Ladetto, M., Specht, L., Thieblemont, C., Walewski, J., Zucca, E. & Jerkeman, M. (2025).
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology,
36(11), 1263-1284.
https://doi.org/10.1016/j.annonc.2025.07.014Holst, J. M., Plesner, T. L., Pedersen, M. B., Ludvigsen, M., Frederiksen, H., Møller, M. B., Wang, R., Tam, W., Inghirami, G.
& d'Amore, F. A. (2017).
Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort.
Blood,
130(Suppl 1), 1525-1525.
Andersen, M. D., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M. & Kamper, P. (2025).
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.
Scientific Reports,
15(1), Article 30273.
https://doi.org/10.1038/s41598-025-16218-8
Ludvigsen, M., Vase, M. Ø., Hjortebjerg, R., Petruskevicius, I., Pedersen, C., Pedersen, G.
, Sørensen, B., Bjerre, M., Obel, N.
, Honoré, B., Larsen, C. S. & d'Amore, F. (2016).
Low Serum Galectin-1 Levels Predict Future Lymphoma Development in HIV-Positive Patients.
Blood,
128(22), Article 2945.
Vähämurto, P., Pollari, M.
, Clausen, M. R., D’amore, F., Leppä, S. & Mannisto, S. (2020).
Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large b-cell lymphoma.
Cancers,
12(7), Article 1967.
https://doi.org/10.3390/cancers12071967Relander, T.
, Pedersen, M. B., Ellin, F., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Holte, H., Österborg, A., Nully Brown, P. D., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Delabie, J., Sundström, C., Sander, B.
, Hamilton-Dutoit, S. J., Ehinger, M., Liestøl, K.
... d'Amore, F. A. (2022).
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial.
Blood,
140(Supplement 1), 1479–1480.
https://doi.org/10.1182Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G. & Pannacciulli, I. (1984).
Leucovorin protection on pluripotent hemopoietic stem cells in mice treated with high-dose methotrexate. Tumori,
70, 223-26.
D'Amore, F. A., Lauritzsen, G. F., Relander, T., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U., Gadeberg, O., Sundstrom, C., Delabie, J., Ralfkiaer, E., Vornanen, M.
& Toldbod, H. (2013).
Late relapses in peripheral T-cell lymphoma patients treated in the nordic NLG-T-01 trial.
Hematological Oncology,
31, 176-177.
Andersen, M. I. D., Hamilton-Dutoit, S., Modvig, L.
, Vase, M., Christiansen, I., Christensen, J. H., Dahl-Sørensen, R. B., Stoltenberg, D.
, Kamper, P. & d'Amore, F. (2022).
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma: A study from the Danish Lymphoma Registry.
British Journal of Haematology,
198(1), 50-61.
https://doi.org/10.1111/bjh.18180
Fischer, A., Albert, T. K., Moreno, N., Interlandi, M., Mormann, J., Glaser, S., Patil, P., de Faria, F. W., Richter, M., Verma, A., Balbach, S. T., Wagener, R., Bens, S., Dahlum, S., Göbel, C., Münter, D., Inserte, C., Graf, M., Kremer, E. ... Kerl, K. (2024).
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Nature Communications,
15(1), 8571. Article 8571.
https://doi.org/10.1038/s41467-024-52826-0Mannisto, S., Vähämurto, P., Pollari, M.
, Clausen, M. R., Jyrkkiö, S., Kellokumpu-Lehtinen, P. L., Kovanen, P., Karjalainen-Lindsberg, M. L.
, d'Amore, F. & Leppä, S. (2019).
Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
European Journal of Cancer,
115, 27-36.
https://doi.org/10.1016/j.ejca.2019.04.004Hybel, T. E., Vase, M. Ø., Maksten, E. F.
, Enemark, M. B., Lauridsen, K. L., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, d'Amore, F. & Ludvigsen, M. (2021).
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Acta Oncologica,
60(12), 1637-1642.
https://doi.org/10.1080/0284186X.2021.1973093
Jantunen, E., Relander, T., Lauritzsen, G., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Østenstad, B., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2011).
Intensive induction chemotherapy followed by autologous stem cell transplantation (ASCT) in patients with enteropathy-associated T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21), 3565.
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2011).
Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn’s Disease: A Predictor of Lymphoma Risk? PLoS One,
6(3), e17890.
https://doi.org/10.1371/journal.pone.0017890
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2010).
Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk? Blood,
116(21), 4131.
Enemark, M. H.
, Jensen, M. L., Andersen, M. D., Plesner, T. L., Hamilton-Dutoit, S. & Ludvigsen, M. (2024).
Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era.
Cancers,
16(20), Article 3553.
https://doi.org/10.3390/cancers16203553Wästerlid, T., Brown, P. D. N., Hagberg, O., Hagberg, H., Pedersen, LM.
, D'Amore, F. A. & Jerkeman, M. (2013).
Impact of chemotherapy regimen and rituximab in adult Burkitt Lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Annals of Oncology,
24(7), 1879-1886.
El-Galaly, T. C., Hutchings, M., Mylam, K. J., de Nully Brown, P.
, Bukh, A., Johnsen, H. E., Kamper, P., Loft, A.
, Iyer, V., Gormsen, L. C., Nielsen, A. L., Bøgsted, M. & d'Amore, F. (2013).
Impact of 18F-FDG PET/CT Staging in Newly Diagnosed Classical Hodgkin Lymphoma: Less Cases with Stage I Disease and More with Skeletal Involvement.
Leukemia & Lymphoma.
https://doi.org/10.3109/10428194.2013.875169
Mandrup-Poulsen, T., Mølvig, J., Andersen, V., Bendtzen, K., Binder, C., Brøns, M.
, d'Amore, F. A., Dieperink, H., Erik, B., Frandsen, NE., Haase, H., Hey, H., Juul, J., Karstoft, E., Kemp, E., Laursen, HB., Mogensen, EF., Nerup, J., Pedersen, KE. ... Sagild, U. (1990).
Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study.
Ugeskrift for Læger,
152(27), 1963-9.
Petersen, M. A., Rosenberg, C. A., Brøndum, R. F.
, Aggerholm, A., Kjeldsen, E., Rahbek, O.
, Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022).
Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
British Journal of Haematology,
197(4), 452-466.
https://doi.org/10.1111/bjh.18094